Deep remission in inflammatory bowel disease: looking beyond symptoms
Clicks: 220
ID: 265834
2013
Inflammatory bowel diseases (IBD) are chronic and disabling conditions. Accumulating evidence indicates that we need to look beyond clinical symptoms as current therapeutic strategies have not modified the course of IBD. Therapeutic goals for IBD have evolved from a mere control of symptoms to mucos …
| Reference Key |
c2013currentdeep
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zallot C;Peyrin-Biroulet L;; |
| Journal | current gastroenterology reports |
| Year | 2013 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Antibodies
Monoclonal
Colitis
biomarkers / analysis
c-reactive protein / analysis
remission induction / methods*
anti-inflammatory agents / therapeutic use
pmid:23354742
doi:10.1007/s11894-013-0315-7
camille zallot
laurent peyrin-biroulet
adalimumab
humanized / therapeutic use
ulcerative* / diagnosis
ulcerative* / drug therapy
ulcerative* / physiopathology
crohn disease* / diagnosis
crohn disease* / drug therapy
crohn disease* / physiopathology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.